MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$47,641K
EPS
-$2.03
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2024-09-30
2024-06-30
License revenue
0
-
1,000
-
Research and development
38,913
37,125
20,439
17,097
General and administrative
9,110
12,730
9,782
3,785
Total operating expenses
48,023
49,855
30,221
20,882
Operating loss
-48,023
-49,855
-29,221
-20,882
Other income, net
-
-
2,087
2,406
Net loss before income taxes
-
-
-27,134
-18,476
Other income, net
371
664
-
-
Net loss
-47,652
-49,191
-27,134
-18,476
Net unrealized gain (loss) on marketable securities
5
-
-
-
Foreign currency translation adjustment
6
18
16
10
Net unrealized loss on marketable securities
-
-11
241
-2
Comprehensive loss
-47,641
-49,184
-26,877
-18,468
Basic EPS
-2.03
-2.34
-1.3
-0.89
Diluted EPS
-2.03
-2.34
-1.3
-0.89
Basic Average Shares
23,487,000
21,010,000
20,876,000
20,852,000
Diluted Average Shares
23,487,000
21,010,000
20,876,000
20,852,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$47,641K
(-77.26%↓ Y/Y)
Foreign currency
translation adjustment
$6K
(-62.50%↓ Y/Y)
Net unrealized gain
(loss) on marketable...
$5K
Net loss
-$47,652K
(-75.62%↓ Y/Y)
Other income, net
$371K
(-82.22%↓ Y/Y)
Operating loss
-$48,023K
(-64.34%↓ Y/Y)
Total operating
expenses
$48,023K
(58.91%↑ Y/Y)
Research and development
$38,913K
(90.39%↑ Y/Y)
General and
administrative
$9,110K
(-6.87%↓ Y/Y)
Buy us a coffee
Adverum Biotechnologies, Inc. (ADVM)
Adverum Biotechnologies, Inc. (ADVM)